HR
Holger Reithinger
Partner at Forbion
Greater Munich Metropolitan Area
Overview
Holger Reithinger is a Venture Capital Investor based in the Greater Munich Metropolitan Area, with a strong track record in early-stage investments in the biopharmaceutical and biotechnology sectors. Notable highlights include serving as a Partner at Forbion, being a Member of the Investment Committee at High-Tech Gründerfonds, and holding board positions in companies such as OMEICOS Therapeutics and Gotham Therapeutics.
Work Experience
Coordinator
2024 - Current
I am co-heading the working group Finance & Taxes at BIO Germany.
Partner
2010
Member of the Investment Committee
2017
Board Member
2013 - 2023
Board Observer
2022 - 2023
Board Member
2018 - 2022
Chairman Of The Board
2016 - 2021
Board Director
2018 - 2020
Gotham is part of New York City’s rapidly growing biopharma community with a subsidiary in one of Europe’s leading life science clusters near Munich, Germany. Forbion co-led the $54 million Series A financing round.
Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.
Raised $54,000,000.00 from Versant Ventures, Forbion Capital Partners and SR One.
Member of the Board
2015 - 2018
Board Director
2014 - 2015
Aufsichtsrat
2015 - 2018